Hepatic Cell News Volume 8.03 | Jan 26 2024

    0
    10







    2024-01-26 | HCN 8.03


    Hepatic Cell News by STEMCELL Technologies
    Vol. 8.03 – 26 January, 2024
    TOP STORY

    Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) Alleviates Hepatic Steatohepatitis via FXR (Farnesoid X Receptor)

    Investigators unraveled that the expression of the transcription factor Zbtb18 was markedly decreased in the livers of both patients and murine models of non-alcoholic fatty liver disease (NAFLD).
    [Signal Transduction And Targeted Therapy]

    Full Article
    Get a Head Start with Our New Lab Start-Up Program
    PUBLICATIONSRanked by the impact factor of the journal

    WNT-Dependent Interaction Between Inflammatory Fibroblasts and FOLR2+ Macrophages Promotes Fibrosis in Chronic Kidney Disease

    Scientists characterized a proinflammatory fibroblast population, which corresponded to an early state of myofibroblast differentiation in chronic kidney disease.
    [Nature Communications]

    Full Article

    YTHDF2 Is a Therapeutic Target for HCC by Suppressing Immune Evasion and Angiogenesis Through ETV5/PD-L1/VEGFA Axis

    Scientists discovered that trimethylated histone H3 lysine 4 and H3 lysine 27 acetylation modification in the promoter region of YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) enhanced its expression in HCC, and upregulated YTHDF2 in HCC predicted a worse prognosis.
    [Advanced Science]

    Full Article

    Neutrophil Extracellular Traps Promote MASH Fibrosis by Metabolic Reprogramming of Hepatic Stellate Cells

    Scientists implicated neutrophil extracellular traps (NETs) playing a critical role in the development of metabolic dysfunction-associated steatohepatitis (MASH)-hepatic fibrosis by inducing metabolic reprogramming of hepatic stellate cells via the TLR3/COX-2/PGE2 pathway.
    [Hepatology]

    AbstractGraphical Abstract

    N6-Methyladenosine Reader YTHDF1 Promotes Stemness and Therapeutic Resistance in Hepatocellular Carcinoma by Enhancing NOTCH1 Expression

    Researchers evaluated the clinical significance of YTHDF1 using human HCC samples and found that YTHDF1 was significantly upregulated in HCCs with high stemness scores and was positively associated with recurrence and poor prognosis.
    [Cancer Research]

    Abstract

    Effect of Donor Age and Liver Steatosis on Potential of Decellularized Liver Matrices to Be Used as a Platform for iPSC-Hepatocyte Culture

    Old donor liver ECM induced lower marker expression in early differentiation stages, compared to young liver ECM, while this difference was closed at later stages and did not affect induced pluripotent stem cell (iPCS)-hepatocyte function significantly.
    [Advanced Healthcare Materials]

    Abstract

    The Inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology

    Researchers elucidated the possible significance of Yes-associated protein (YAP) inhibition in biliary fibrosis by examining the pathophysiology of hepatic stellate cells and biliary epithelial cells
    [Aging And Disease]

    Abstract

    Circular RNA cVIM Promotes Hepatic Stellate Cell Activation in Liver Fibrosis via miR-122-5p/miR-9-5p-Mediated TGF-β Signaling Cascade

    Investigators demonstrated a vital role for cVIM in promoting liver fibrosis progression and provide a fresh perspective on circRNAs in liver fibrosis.
    [Communications Biology]

    Full Article

    Single-Cell Landscape Identifies the Immunophenotypes and Microenvironments of HBV-Positive and HBV-Negative Liver Cancer

    Researchers explored the tumor ecosystem in HCC to help gain a deeper understanding and design more effective immunotherapy strategies for patients with HCC with or without hepatitis B virus infection.
    [Hepatology Communications]

    Full Article
    Request a free wallchart for a quick reference on growing organoids from stem cells.
    REVIEWS

    Liver Sinusoidal Endothelial Cells As Potential Drivers of Liver Fibrosis

    Scientists summarized changes in liver sinusoidal endothelial cells (LSECs) during liver fibrosis and their interactions with hepatic milieu, as well as possible therapeutic approaches that specifically target LSECs.
    [Molecular Medicine Reports]

    Full Article
    INDUSTRY AND POLICY NEWS

    Ozempic: Popular Weight Loss Drug May Also Prevent Liver Disease

    Early studies have shown that Ozempic and other similar drugs may reduce liver damage. Researchers at Karolinska Institutet conducted a register-based study including all people in Sweden with chronic liver disease and Type 2 diabetes.
    [Study Finds]

    Press Release
    FEATURED EVENT

    Tandem Meetings Transplantation & Cellular Therapy Meetings of ASTCT® and CIBMTR®

    February 21 – 24, 2024
    San Antonio, Texas, United States

    > See All Events

    JOB OPPORTUNITIES

    Research Fellow – Achieving Functional Cure of Chronic Hepatitis B

    National University of Singapore – Singapore, Singapore

    Research Fellow – iPSCs and/or Hepatobiology

    National University of Singapore – Singapore, Singapore

    Research Fellowship – Hepatocellular Carcinoma

    Instituto de Investiga̤̣o e Inova̤̣o em Sa̼de da Universidade do Porto РPorto, Portugal

    Postdoctoral Researchers – Advanced Imaging & 3D Genome Analysis in Cancer Biology

    Karolinska Institutet – Solna, Sweden

    Research Fellow – Structural Biology of RNA

    University of Birmingham – Birmingham, England, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2